These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11790930)

  • 1. Advances in implantable cardioverter defibrillators.
    Swygman C; Wang PJ; Link MS; Homoud MK; Estes NA
    Curr Opin Cardiol; 2002 Jan; 17(1):24-8. PubMed ID: 11790930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?
    Lee KL; Lau CP
    Curr Cardiol Rep; 2001 Nov; 3(6):447-50. PubMed ID: 11602074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technologic advances in implantable cardioverter defibrillators.
    Swygman CA; Homoud MK; Link MS; Wang PJ; Estes NA
    Curr Opin Cardiol; 1999 Jan; 14(1):9-14. PubMed ID: 9932202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications.
    Rao BH; Saksena S
    Curr Opin Crit Care; 2003 Oct; 9(5):362-8. PubMed ID: 14508148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
    Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
    Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implantable cardioverter defibrillator.
    Glikson M; Friedman PA
    Lancet; 2001 Apr; 357(9262):1107-17. PubMed ID: 11297981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators.
    Pinski SL; Fahy GJ
    Am J Med; 1999 Apr; 106(4):446-58. PubMed ID: 10225249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preview of implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach.
    Morris MM; KenKnight BH; Warren JA; Lang DJ
    Am J Cardiol; 1999 Mar; 83(5B):48D-54D. PubMed ID: 10089840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer Indications for ICD and CRT.
    Merriam JA; Rajendra AB; Gold MR
    Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.